Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Liana K. Mathias, Patrick J. Monette, David G. Harper & Brent P. Forester. (2017) Application of magnetic resonance spectroscopy in geriatric mood disorders. International Review of Psychiatry 29:6, pages 597-617.
Read now
Read now
Eva Maria Pichler, Georg Hattwich, Heinz Grunze & Moritz Muehlbacher. (2015) Safety and tolerability of anticonvulsant medication in bipolar disorder. Expert Opinion on Drug Safety 14:11, pages 1703-1724.
Read now
Read now
Articles from other publishers (12)
Yasuhiko Hashimoto, Kazumasa Kotake, Norio Watanabe, Takashi Fujiwara & Shinji Sakamoto. (2021) Lamotrigine in the maintenance treatment of bipolar disorder. Cochrane Database of Systematic Reviews 2021:9.
Crossref
Crossref
Yasuhiko Hashimoto, Kazumasa Kotake, Norio Watanabe, Takashi Fujiwara & Shinji Sakamoto. (2020) Lamotrigine in the maintenance treatment of bipolar disorder. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Somaia M. Abdel‐kariem. (2019) Synthesis of Some Novel Thiadiazaphosphole, Oxazaphospholothiadiazaphosphole, Thiadiazaphosphinine, and Phosphonates Containing a 1,2,4‐Triazine Moiety. Journal of Heterocyclic Chemistry 56:7, pages 1922-1927.
Crossref
Crossref
Marco Solmi, Nicola Veronese, Leonardo Zaninotto, Marc L. M. van der Loos, Keming Gao, Ayal Schaffer, Catherine Reis, Claus Normann, Ion-George Anghelescu & Christoph U. Correll. (2016) Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials. CNS Spectrums 21:5, pages 403-418.
Crossref
Crossref
Marc Masson & Gilles Huberfeld. (2016) Que soignent les traitements anticonvulsivants ? Effets positifs et négatifs des médicaments antiépileptiques en psychiatrie. Annales Médico-psychologiques, revue psychiatrique 174:2, pages 128-134.
Crossref
Crossref
Edoardo Spina & Domenico Italiano. 2016. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents
177
203
.
Gin S Malhi, Darryl Bassett, Philip Boyce, Richard Bryant, Paul B Fitzgerald, Kristina Fritz, Malcolm Hopwood, Bill Lyndon, Roger Mulder, Greg Murray, Richard Porter & Ajeet B Singh. (2015) Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Australian & New Zealand Journal of Psychiatry 49:12, pages 1087-1206.
Crossref
Crossref
Kedar S. Prabhavalkar, Nimmy B. Poovanpallil & Lokesh K. Bhatt. (2015) Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer. Frontiers in Pharmacology 6.
Crossref
Crossref
Marco Di Nicola, Luisa De Risio, Mauro Pettorruso, Giulio Caselli, Franco De Crescenzo, Kevin Swierkosz-Lenart, Giovanni Martinotti, Giovanni Camardese, Massimo Di Giannantonio & Luigi Janiri. (2014) Bipolar disorder and gambling disorder comorbidity: Current evidence and implications for pharmacological treatment. Journal of Affective Disorders 167, pages 285-298.
Crossref
Crossref
Young Sup Woo, Won-Myong Bahk, Chi-Un Pae, Jong-Hyun Jeong, Bon-Hoon Koo, Duk-In Jon, Jung Goo Lee & Moon-Doo Kim. (2014) Observational study to evaluate the clinical benefit of lamotrigine add-on therapy in bipolar patients in a naturalistic treatment setting. Asia-Pacific Psychiatry 6:3, pages 334-341.
Crossref
Crossref
Wolfgang Löscher, Henrik Klitgaard, Roy E. Twyman & Dieter Schmidt. (2013) New avenues for anti-epileptic drug discovery and development. Nature Reviews Drug Discovery 12:10, pages 757-776.
Crossref
Crossref
Laura Musetti, Claudia Del Grande, Donatella Marazziti & Liliana Dell'Osso. (2013) Treatment of bipolar depression. CNS Spectrums 18:4, pages 177-187.
Crossref
Crossref